Skip to main content
. Author manuscript; available in PMC: 2022 May 11.
Published in final edited form as: J Alzheimers Dis. 2021;83(3):1379–1389. doi: 10.3233/JAD-210588

Table 2.

Odds of incident cognitive impairment by imputed depressive symptom time weighted averages adjusted for age, sex, race, cohort, and anti-depressant use (n = 5,098:2,906 CHS and 2,192 HABC participants)

Separate models for each life course period (Primary Analysis)

Early Adulthood Mid-life Late-life

CESD-10 OR (95% CI) OR (95% CI) OR (95% CI)
Low (0–3) ref ref ref
Moderate (4–10) 1.59 (1.35, 1.89) 1.33 (1.17, 1.51) 1.34 (1.19, 1.50)
High (10+) NA* 1.94 (1.16, 3.26) 1.77 (1.42, 2.21)

One model, each life course period adjusted for other periods (Secondary Analysis)

CESD-10 Early Adulthood Mid-life Late-life

Low (0–3) ref ref ref
Moderate (4–10) 1.38 (1.14, 1.68) 1.00 (0.85, 1.19) 1.29 (1.14, 1.47)
High (10+) NA* 1.16 (0.65, 2.06) 1.47 (1.12, 1.93)
*

No participants had imputed young adulthood TWAs in this range.